CAITLIN DAUGHTRY: Open Payments
NPI 1215571054 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,219 in 104 payments from 17 companies in 2025. Trend: 2023 $1,619 · 2024 $2,210 · 2025 $2,219
Food & beverage: $2,219
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $354 |
| Axsome Therapeutics, Inc. | 12 | $325 |
| Janssen Pharmaceuticals, Inc | 9 | $279 |
| ABBVIE INC. | 19 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $160 |
| Lundbeck LLC | 18 | $143 |
| TMS NeuroHealth Centers Inc. | 3 | $113 |
| Bausch Health US, LLC | 5 | $100 |
| Corium, LLC | 4 | $99 |
| Collegium Pharmaceutical, Inc. | 5 | $91 |
Products named: REXULTI, Auvelity, SPRAVATO, VRAYLAR, CAPLYTA, TMS NeuroHealth Centers Inc., APLENZIN, Azstarys.
Industry payments across IL — which companies pay providers there.
